Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper
Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study
The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper
Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?
Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain
